Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson's disease on MRI.
Atrophy
Brainstem
Dementia with Lewy Bodies
MRI
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
21 Mar 2023
21 Mar 2023
Historique:
received:
21
12
2022
accepted:
08
03
2023
entrez:
22
3
2023
pubmed:
23
3
2023
medline:
24
3
2023
Statut:
epublish
Résumé
Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. While current MRI research focuses primarily on atrophy patterns of the frontal and temporal lobes, we focus on brainstem characteristics of DLB. In particular, we focused on brainstem atrophy patterns distinguishing DLB from Progressive Supranuclear Palsy (PSP) and PD based as the most common differential diagnoses. We identified patients diagnosed with DLB, PD, PSP, and a control group (CTRL) in our psychiatric and neurological archives. All patients with competing diagnoses and without a high-quality T1 MPRAGE 3D dataset were excluded. We assessed atrophy patterns in all patients (1) manually and (2) using FastSurfer's segmentation algorithm in combination with FreeSurfer's brainstem volumetric calculations. We compared classical measurement methods and ratios with automated volumetric approaches. One hundred two patients were enrolled and evaluated in this study. Patients with DLB (n = 37) showed on average less atrophy of the brainstem than patients with PSP (n = 21), but a significantly more pronounced atrophy than patients with PD (n = 36) and the control group (CTRL, n = 8). The mean measured sagittal diameters of the midbrain were 8.17 ± 1.06 mm (mean ± standard deviation) for PSP, 9.45 ± 0.95 mm for DLB, 10.37 ± 0.99 mm for PD and 10.74 ± 0.70 for CTRL. The mean measured areas of the midbrain were 81 ± 18 mm DLB patients exhibit homogenous atrophy of the brainstem and can be distinguished from patients with PSP and PD by both manual measurement methods and automated volume segmentation using absolute values or ratios.
Sections du résumé
BACKGROUND
BACKGROUND
Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. While current MRI research focuses primarily on atrophy patterns of the frontal and temporal lobes, we focus on brainstem characteristics of DLB. In particular, we focused on brainstem atrophy patterns distinguishing DLB from Progressive Supranuclear Palsy (PSP) and PD based as the most common differential diagnoses.
METHODS
METHODS
We identified patients diagnosed with DLB, PD, PSP, and a control group (CTRL) in our psychiatric and neurological archives. All patients with competing diagnoses and without a high-quality T1 MPRAGE 3D dataset were excluded. We assessed atrophy patterns in all patients (1) manually and (2) using FastSurfer's segmentation algorithm in combination with FreeSurfer's brainstem volumetric calculations. We compared classical measurement methods and ratios with automated volumetric approaches.
RESULTS
RESULTS
One hundred two patients were enrolled and evaluated in this study. Patients with DLB (n = 37) showed on average less atrophy of the brainstem than patients with PSP (n = 21), but a significantly more pronounced atrophy than patients with PD (n = 36) and the control group (CTRL, n = 8). The mean measured sagittal diameters of the midbrain were 8.17 ± 1.06 mm (mean ± standard deviation) for PSP, 9.45 ± 0.95 mm for DLB, 10.37 ± 0.99 mm for PD and 10.74 ± 0.70 for CTRL. The mean measured areas of the midbrain were 81 ± 18 mm
CONCLUSIONS
CONCLUSIONS
DLB patients exhibit homogenous atrophy of the brainstem and can be distinguished from patients with PSP and PD by both manual measurement methods and automated volume segmentation using absolute values or ratios.
Identifiants
pubmed: 36944914
doi: 10.1186/s12883-023-03151-4
pii: 10.1186/s12883-023-03151-4
pmc: PMC10029226
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114Informations de copyright
© 2023. The Author(s).
Références
Radiology. 2008 Jan;246(1):214-21
pubmed: 17991785
PLoS One. 2009 Dec 10;4(12):e8247
pubmed: 20011063
BMC Neurol. 2022 Mar 24;22(1):114
pubmed: 35331168
Neuroradiol J. 2022 Dec;35(6):684-691
pubmed: 35446175
Mov Disord. 2006 Jul;21(7):989-96
pubmed: 16602104
Eur J Neurol. 2017 Jan;24(1):212-218
pubmed: 27747983
Front Aging Neurosci. 2022 Oct 05;14:815813
pubmed: 36274999
BMJ Open. 2020 Aug 13;10(8):e038120
pubmed: 32792445
Neuroimage. 2015 Jun;113:184-95
pubmed: 25776214
Neuroimage. 2012 Aug 15;62(2):774-81
pubmed: 22248573
Mov Disord. 2005 Aug;20 Suppl 12:S11-20
pubmed: 16092075
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Lancet. 2015 Oct 24;386(10004):1683-97
pubmed: 26595642
Neuroimage. 2020 Oct 1;219:117012
pubmed: 32526386
Neurology. 2011 Sep 13;77(11):1042-7
pubmed: 21832222
Brain. 2006 Apr;129(Pt 4):1040-9
pubmed: 16455792
Neurology. 1967 May;17(5):427-42
pubmed: 6067254
Neurology. 2013 May 14;80(20):1856-61
pubmed: 23616165
Magn Reson Imaging. 2017 Feb;36:49-55
pubmed: 27989908
Psychol Med. 2014 Mar;44(4):673-83
pubmed: 23521899
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Eur J Neurol. 2017 Jul;24(7):956-965
pubmed: 28510312
Biometrics. 1949 Jun;5(2):99-114
pubmed: 18151955
Parkinsonism Relat Disord. 2018 Sep;54:3-8
pubmed: 30068492
J Alzheimers Dis. 2010;22(1):195-203
pubmed: 20847421
Mov Disord. 2011 Feb 15;26(3):527-33
pubmed: 21287599
Parkinsonism Relat Disord. 2020 Oct;79:18-25
pubmed: 32858488
Mov Disord. 2020 Jun;35(6):976-983
pubmed: 32092195
Neurol Sci. 2017 Apr;38(4):627-633
pubmed: 28078564
Mov Disord. 2021 Feb;36(2):460-470
pubmed: 33137232
Psychol Bull. 1979 Mar;86(2):420-8
pubmed: 18839484
Neuroimage. 2010 Jun;51(2):512-20
pubmed: 20211271
Mov Disord. 2015 Oct;30(12):1591-601
pubmed: 26474316
J Neurol. 2021 Apr;268(4):1526-1532
pubmed: 33277666
Eur Neurol. 1996;36(5):268-72
pubmed: 8864706
Neurology. 2005 Jun 28;64(12):2050-5
pubmed: 15985570
Brain Pathol. 2015 Mar;25(2):121-35
pubmed: 24995389
PLoS One. 2018 Jun 14;13(6):e0198250
pubmed: 29902203
J Neurol. 2008 Jan;255(1):37-44
pubmed: 18080856
Neurology. 2005 Feb 22;64(4):675-9
pubmed: 15728291